Skip to content
Nexusuro
All articles | Hospital Adoption

Integrating a New BPH MIST into Hospital Urology Workflow

May 20, 2026 |6 min read | Nexusuro Insights
Hospital urology department adopting new BPH MIST procedure

Adding a new BPH treatment modality to a hospital urology department involves more than purchasing equipment. The workflow impact — on scheduling, staff training, patient education, and reimbursement — determines whether adoption succeeds or stalls.

The workflow assessment

Before committing to a new procedure, hospitals should map the current BPH patient journey against what the new modality requires. Key friction points include: procedure room type (OR vs. treatment room), anesthesia requirements (general vs. sedation), staffing needs (urologist-only vs. team), and post-procedure monitoring (inpatient vs. same-day discharge).

Training economics

Procedure learning curves directly affect adoption speed. TUCBDP's short learning curve — urologists with endoscopic experience can achieve proficiency after a few supervised cases — means hospitals can train multiple staff urologists in weeks rather than sending one surgeon away for months. This parallel training model accelerates the path to sustainable procedure volume.

Equipment and capital

Procedures requiring dedicated capital equipment (laser generators, RF consoles) create a single-point-of-failure: if the equipment is down, the procedure is down. TUCBDP's reliance on standard endoscopy — equipment most urology departments already own and maintain — eliminates this dependency.

Patient communication strategy

When a hospital adds a new procedure, patient awareness lags behind clinical capability. A structured patient communication strategy — including updated website content, referring physician education, and waiting room materials — helps bridge the gap between offering a procedure and patients knowing it exists.

Share this article

Stay informed on BPH MIST developments

More articles on clinical evidence, technology pathways, and international market observations.

Nexusuro Insights is for informational purposes. Content does not constitute medical advice.